Received for publication January 18, 2006.
Revised March 21, 2006.
Accepted for publication March 22, 2006.

Dual potentiating and inhibitory actions of a benz[e]indene neurosteroid analogue on recombinant 122 GABA_A receptors

Abstract

Benz[e]indenes are tricyclic analogues of neuroactive steroids and can be modulators of GABA_A receptor activity. We have examined the mechanisms of action of a benz[e]indene compound [3S-(3,3a,5a,7,9a,9b)]-dodecahydro-7-(2-hydroxyethyl)-3a-methyl-1H-benz[e]indene-3-carbonitrile (BI-2) using single-channel patch clamp and whole-cell recordings from HEK cells transfected with rat GABA_A receptor 1, 2, 2L subunits. The data demonstrate that BI-2 is a positive modulator of GABA_A receptor activity with a peak effect at 2 µM. The mechanism of modulation is similar but not identical to that of neuroactive steroids. Similar to steroids, BI-2 acts by prolonging the mean open time duration through an effect on the duration and prevalence of the longest open time component. However, in contrast to many steroids, BI-2 does not selectively reduce the channel closing rate. The potentiating action of BI-2 appears to be mediated through interactions with the classical neuroactive steroid binding site. Mutation to the membrane-spanning regions in the 1 subunit, Q242W and the double mutation 1N408A/Y411F, previously shown to abolish potentiation by neurosteroids, also diminish potentiation by BI-2. At higher concentrations (>5 µM), BI-2 inhibits receptor function by enhancing the apparent rate of desensitization. From single-channel recordings, we estimate that the entry rate into the inhibited or blocked state, k_+B, is 0.50 µM^-1s^-1. Based on the kinetic mechanism of action, and the finding that this effect is blocked by the 1V256S mutation, we propose that BI-2 acts through an inhibitory site first postulated for the inhibitory neurosteroid pregnenolone sulfate.

Key words: GABAA, GABAC, Func. analysis receptor/ion channel mutants, Single channel kinetics

This article has been cited by other articles:

				J. R. Bracamontes and J. H. Steinbach Multiple Modes for Conferring Surface Expression of Homomeric {beta}1 GABAA Receptors J. Biol. Chem., September 19, 2008; 283(38): 26128 - 26136. [Abstract] [Full Text] [PDF]

				G. Akk, P. Li, J. Bracamontes, D. E. Reichert, D. F. Covey, and J. H. Steinbach Mutations of the GABA-A Receptor {alpha}1 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive Steroids Mol. Pharmacol., September 1, 2008; 74(3): 614 - 627. [Abstract] [Full Text] [PDF]

				A. Keramidas and N. L. Harrison Agonist-dependent Single Channel Current and Gating in {alpha}4{beta}2{delta} and {alpha}1{beta}2{gamma}2S GABAA Receptors J. Gen. Physiol., January 28, 2008; 131(2): 163 - 181. [Abstract] [Full Text] [PDF]

				P. Li, H.-J. Shu, C. Wang, S. Mennerick, C. F. Zorumski, D. F. Covey, J. H. Steinbach, and G. Akk Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation J. Physiol., November 1, 2007; 584(3): 789 - 800. [Abstract] [Full Text] [PDF]

				W. Li, X. Jin, D. F. Covey, and J. H. Steinbach Neuroactive Steroids and Human Recombinant {rho}1 GABA Receptors J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 236 - 247. [Abstract] [Full Text] [PDF]

				P. Li, J. Bracamontes, B. W. Katona, D. F. Covey, J. H. Steinbach, and G. Akk Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat {alpha}1beta2{gamma}2L GABAA Receptor Mol. Pharmacol., June 1, 2007; 71(6): 1582 - 1590. [Abstract] [Full Text] [PDF]

				G. Akk, P. Li, B. D. Manion, A. S. Evers, and J. H. Steinbach Ethanol Modulates the Interaction of the Endogenous Neurosteroid Allopregnanolone with the {alpha}1beta2{gamma}2L GABAA Receptor Mol. Pharmacol., February 1, 2007; 71(2): 461 - 472. [Abstract] [Full Text] [PDF]